221 related articles for article (PubMed ID: 29607787)
21. Anti-melanogenesis of novel kojic acid derivatives in B16F10 cells and zebrafish.
Chen YM; Su WC; Li C; Shi Y; Chen QX; Zheng J; Tang DL; Chen SM; Wang Q
Int J Biol Macromol; 2019 Feb; 123():723-731. PubMed ID: 30414415
[TBL] [Abstract][Full Text] [Related]
22. N-(3,5-dimethylphenyl)-3-methoxybenzamide (A(3)B(5)) targets TRP-2 and inhibits melanogenesis and melanoma growth.
Lee EJ; Lee YS; Hwang S; Kim S; Hwang JS; Kim TY
J Invest Dermatol; 2011 Aug; 131(8):1701-9. PubMed ID: 21525883
[TBL] [Abstract][Full Text] [Related]
23. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
[TBL] [Abstract][Full Text] [Related]
24. Depigmenting effect of Kojic acid esters in hyperpigmented B16F1 melanoma cells.
Lajis AF; Hamid M; Ariff AB
J Biomed Biotechnol; 2012; 2012():952452. PubMed ID: 23091364
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Evaluation of Antioxidant and Cytotoxicity of the N-Mannich Base of Berberine Bearing Benzothiazole Moieties.
Mistry BM; Shin HS; Keum YS; Pandurangan M; Kim DH; Moon SH; Kadam AA; Shinde SK; Patel RV
Anticancer Agents Med Chem; 2017; 17(12):1652-1660. PubMed ID: 28699489
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic activities of Mannich bases of chalcones and related compounds.
Dimmock JR; Kandepu NM; Hetherington M; Quail JW; Pugazhenthi U; Sudom AM; Chamankhah M; Rose P; Pass E; Allen TM; Halleran S; Szydlowski J; Mutus B; Tannous M; Manavathu EK; Myers TG; De Clercq E; Balzarini J
J Med Chem; 1998 Mar; 41(7):1014-26. PubMed ID: 9544201
[TBL] [Abstract][Full Text] [Related]
27. Kojic acid applications in cosmetic and pharmaceutical preparations.
Saeedi M; Eslamifar M; Khezri K
Biomed Pharmacother; 2019 Feb; 110():582-593. PubMed ID: 30537675
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of UVA-mediated melanogenesis by ascorbic acid through modulation of antioxidant defense and nitric oxide system.
Panich U; Tangsupa-a-nan V; Onkoksoong T; Kongtaphan K; Kasetsinsombat K; Akarasereenont P; Wongkajornsilp A
Arch Pharm Res; 2011 May; 34(5):811-20. PubMed ID: 21656367
[TBL] [Abstract][Full Text] [Related]
29. Kojic acid-induced IL-6 production in human keratinocytes plays a role in its anti-melanogenic activity in skin.
Choi H; Kim K; Han J; Choi H; Jin SH; Lee EK; Shin DW; Lee TR; Lee AY; Noh M
J Dermatol Sci; 2012 Jun; 66(3):207-15. PubMed ID: 22464230
[TBL] [Abstract][Full Text] [Related]
30. Anticonvulsant and neurotoxicity evaluation of some novel kojic acids and allomaltol derivatives.
Aytemir MD; Calis U
Arch Pharm (Weinheim); 2010 Mar; 343(3):173-81. PubMed ID: 20108269
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, Anticancer Activity and Molecular Docking Studies of Novel
Strzelecka M; Glomb T; Drąg-Zalesińska M; Kulbacka J; Szewczyk A; Saczko J; Kasperkiewicz-Wasilewska P; Rembiałkowska N; Wojtkowiak K; Jezierska A; Świątek P
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232475
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory activity of novel kojic acid derivative containing trolox moiety on melanogenesis.
Ahn SM; Rho HS; Baek HS; Joo YH; Hong YD; Shin SS; Park YH; Park SN
Bioorg Med Chem Lett; 2011 Dec; 21(24):7466-9. PubMed ID: 22071299
[TBL] [Abstract][Full Text] [Related]
33. Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells.
Cheng SL; Huang Liu R; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
Biol Pharm Bull; 2006 Apr; 29(4):655-69. PubMed ID: 16595896
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of melanogenesis by 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908).
Park MH; Kim SJ; Jeong HO; Moon KM; Son S; Kim DH; Kim HR; Kim MJ; Yun HY; Chun P; Je NK; Yokozawa T; Moon HR; Chung HY
Arch Pharm Res; 2015 Apr; 38(4):505-11. PubMed ID: 25502981
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cytotoxic properties of new N-substituted 4-aminophenol derivatives with a potential as antimelanoma agents.
Mascagna D; Ghanem G; Morandini R; d'Ischia M; Misuraca G; Lejeune F; Prota G
Melanoma Res; 1992 May; 2(1):25-32. PubMed ID: 1643421
[TBL] [Abstract][Full Text] [Related]
36. Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents.
Dong Y; Shi Q; Nakagawa-Goto K; Wu PC; Morris-Natschke SL; Brossi A; Bastow KF; Lang JY; Hung MC; Lee KH
Bioorg Med Chem; 2010 Jan; 18(2):803-8. PubMed ID: 20034799
[TBL] [Abstract][Full Text] [Related]
37. Adamantyl pyran-4-one derivatives and their in vitro antiproliferative activity.
Peroković VP; Car Ž; Usenik A; Opačak-Bernardi T; Jurić A; Tomić S
Mol Divers; 2020 Feb; 24(1):253-263. PubMed ID: 30953295
[TBL] [Abstract][Full Text] [Related]
38. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents.
Dooley TP; Gadwood RC; Kilgore K; Thomasco LM
Skin Pharmacol; 1994; 7(4):188-200. PubMed ID: 8024800
[TBL] [Abstract][Full Text] [Related]
39. One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic--lasalocid acid.
Huczyński A; Rutkowski J; Borowicz I; Wietrzyk J; Maj E; Brzezinski B
Bioorg Med Chem Lett; 2013 Sep; 23(18):5053-6. PubMed ID: 23932361
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Antiproliferative Activity of Thioxoflavones Mannich Base Derivatives.
Li W; Li X; Liu M; Wang Q
Arch Pharm (Weinheim); 2017 Jul; 350(7):. PubMed ID: 28605048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
